News ArticleStrides Pharma Science Names Biren Gabhawala as Independent Director Effective November 2026
Experienced Chartered Accountant with over 30 years in finance appointed for a five-year term, advancing board governance and risk management
Strides Pharma Science Limited has appointed Mr. Biren Gabhawala as a Non-Executive Independent Director effective November 1, 2026, for a five-year term. With over 30 years of experience in finance, audit, and regulatory matters, Gabhawala's addition aims to enhance the company’s board oversight and governance.
Strides Pharma Science Limited
Change in Management
Strides Pharma Science Limited announced the appointment of Biren Gabhawala as a Non-Executive Independent Director effective November 1, 2026, for a five-year term. Gabhawala brings extensive expertise in finance, audit, taxation, and corporate governance from his over three decades of professional experience.
Mr. Biren Gabhawala is a Chartered Accountant and Fellow Member of the Institute of Chartered Accountants of India with significant experience in financial reporting, audit, taxation, valuations, and regulatory compliance.
Gabhawala has been the Senior Partner at C.M. Gabhawala & Co. since 1987 and has served as an Independent Director and Audit Committee Chair for listed companies including eClerx Services Limited and 3M India Limited.
His appointment is part of Strides Pharma Science’s planned board succession strategy to strengthen financial oversight, risk management, internal controls, and corporate governance.
The term of appointment is for five years, during which Gabhawala will not be liable to retire by rotation, subject to shareholder approval.
No relationship exists between Mr. Gabhawala and other directors of the company, and he is not barred by any regulatory authority from holding directorship.
Highlights
- Appointment effective from November 1, 2026, with a five-year term
- Biren Gabhawala is a Chartered Accountant with over 30 years of expertise
- Served on boards and audit committees of listed companies such as 3M India and eClerx Services
- Appointment aligns with the company’s board succession planning initiative
- No director relationships or regulatory disqualifications reported
Key Data Snapshot
What happened
- Strides Pharma Science appointed Mr. Biren Gabhawala as a Non-Executive Independent Director effective November 1, 2026.
- His appointment is for a five-year term, subject to shareholder approval.
- This appointment is part of the company’s planned board succession initiatives.
Key details
- Gabhawala is a Chartered Accountant and Fellow Member of the Institute of Chartered Accountants of India.
- He has over 30 years of experience in accounting, audit, taxation, financial reporting, corporate finance, valuations, and regulatory matters.
- He is the Senior Partner at C.M. Gabhawala & Co. since 1987.
- He has served as Independent Director and Audit Committee Chair of eClerx Services Limited and 3M India Limited.
- There are no relationships between Mr. Gabhawala and existing directors.
- He is not debarred by SEBI or any statutory authority from holding the office of director.
Regulatory and governance context
- The appointment is disclosed pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015.
- Mr. Gabhawala’s appointment is subject to shareholder approval.
- He is not liable to retire by rotation during his five-year term.
Highlights
- Appointment effective from November 1, 2026, with a five-year term
- Biren Gabhawala is a Chartered Accountant with over 30 years of expertise
- Served on boards and audit committees of listed companies such as 3M India and eClerx Services
- Appointment aligns with the company’s board succession planning initiative
- No director relationships or regulatory disqualifications reported
Disclosures
- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source Information
More News on Change in Management
View allLatest corporate announcements and market updates in Change in Management.
Trent Limited Names Bahram Vakil as New Chairman Following Noel Tata’s Retirement, Adds Rajiv Dube and Kalpana Merchant to Board
Trent Limited announced multiple leadership changes: Chairman Noel N. Tata will retire on 11th November 2026 and be appointed Chairman Emeritus, Mr. Bahram Vakil will assume the Chairman role from 12th November 2026, alongside director appointments of Mr. Rajiv Dube and Ms. Kalpana Merchant effective 30th October 2026, with Merchant serving a three-year independent director term.
Read Full Story
Vedanta Oil and Gas Limited Names Rupesh Kumar as New Company Secretary & Compliance Officer from November 1, 2026
Vedanta Oil and Gas Limited announced a change in its Company Secretary and Compliance Officer following the resignation of Ms. Shivangi Dhanuka, effective October 31, 2026, and the appointment of Mr. Rupesh Kumar effective November 1, 2026.
Read Full Story
Blue Star Limited Names Mr. Nithianand S and Mr. Senthil Thangam as Senior Management Leaders Effective November 1, 2026
Blue Star Limited has appointed Mr. Nithianand S as Group President, Supply Chain & Procurement and Mr. Senthil Thangam as President, Air Conditioning & Refrigeration Solutions Group, with both appointments effective from November 1, 2026.
Read Full Story
